Acquired Penile Curvature
A change in the direction of the penis upward, downward, or to either side, mainly noticed during an erection.
Peyronie’s Disease is an acquired condition associated with the formation of scar tissue in the tunica albuginea, the layer of tissue surrounding the erectile chambers of the penis. During an erection, this area may restrict tissue expansion and cause curvature or other deformities.
Congenital curvature and acquired changes have different causes and require different forms of evaluation.
Some men notice pain or a plaque, while others seek evaluation because of a change in penile shape or erection quality.
The stage of the condition, the deformity, erectile function, and sexual impact help guide treatment.
Tell us what you have noticed to receive initial guidance on the next steps.
The condition is not limited to the angle of curvature. Narrowing, instability, pain, and changes in erection firmness can also affect sexual intercourse and overall well-being.
A change in the direction of the penis upward, downward, or to either side, mainly noticed during an erection.
The scar tissue may be felt by touch, although not every plaque is easily palpable.
Pain is more common while the condition is changing, but it may decrease even when the deformity persists.
An indentation or localized narrowing may cause instability, even without pronounced curvature.
Shortening may be noticed or measured and should be evaluated along with other anatomical changes.
Erection firmness may be affected, and the deformity may make intercourse difficult in some cases.
Speak with our team to learn how the urological evaluation works.
The exact cause is not always identified. The most widely accepted explanation involves an abnormal healing response after trauma or repeated minor injuries, although many patients do not recall a specific injury.
Small injuries to the tunica albuginea may contribute to the process in people with a predisposition. This does not mean that every sexual encounter, exercise, or injury causes the condition, nor does it allow a single event to be identified as the cause.
Age, family history, diabetes, smoking, erectile dysfunction, and connective tissue conditions such as Dupuytren’s contracture may be associated with Peyronie’s Disease. None of these factors alone confirms the cause or diagnosis.
Evaluation should be conducted without guilt or embarrassment. The goal is to understand progression, relevant clinical factors, and the impact of these changes on sexual function.
Describe the changes you have noticed in the preliminary assessment. You do not need to know the cause before seeking guidance.
The distinction between these phases is clinical. There is no fixed number of months that applies to everyone, which is why tracking pain and changes in shape is more important than focusing on a specific date.
There may be current or recent pain, plaque formation or remodeling, and changes in curvature, length, girth, or other deformities. The focus is typically on monitoring progression, managing symptoms, and assessing appropriate non-surgical options.
The curvature and other changes no longer show noticeable progression during follow-up, and pain has usually decreased or resolved. The chronic phase helps determine when reconstructive procedures may be discussed if there is significant functional impairment.
Pain, curvature, narrowing, and erectile function may change in different ways. The evaluation should consider all symptoms and their impact on sexual life.
Share how your symptoms have progressed to help guide the initial contact. This does not replace a medical evaluation.
Diagnosis is primarily clinical and should not be confirmed solely through a form, an isolated photograph, or information found online.
Onset of symptoms, pain, changes in shape, erection firmness, previous treatments, and impact on sexual intercourse.
Inspection, palpation of the plaque, and assessment of penile dimensions and anatomical characteristics.
Curvature should be assessed during an erection, using guided documentation or an in-office test.
Doppler ultrasound may help assess erectile function, the plaque, and treatment planning.
Doppler ultrasound may be requested in selected situations to assess erectile function and assist with treatment planning. It is not required to confirm every case of Peyronie’s Disease.
Our team can explain how care works and guide you through the next steps toward an appointment.
In this video, Dr. Paulo Egydio explains the signs of the condition, how the evaluation is performed, and why treatment options depend on the stage of the condition, anatomy, and erectile function.
The preliminary assessment organizes your medical history and helps guide the next contact; it does not confirm a diagnosis.
There is no single treatment option that is appropriate for everyone. Treatment may aim to manage pain, monitor progression, improve erectile function, reduce deformity, or make sexual intercourse easier.
These may include observation, pain management, treatment for erectile dysfunction, and intralesional therapies for selected patients.
These may be considered for specific goals, such as addressing deformity, preserving length, and supporting function.
These are primarily discussed during the chronic phase, when the deformity causes significant functional impairment.
The preliminary assessment is a starting point for organizing your symptoms and previous treatments.
Clinical treatment depends on the symptom being addressed. There is no pill or supplement proven to dissolve the plaque and correct all deformities on its own.
Medications such as phosphodiesterase type 5 inhibitors may be considered when erectile dysfunction is present. Their primary role is to improve erectile response, not to directly correct curvature caused by scar tissue.
The choice depends on cardiovascular health, other medications being used, and individual response, and should always be made with a medical prescription.
Xiaflex® is the brand name for collagenase Clostridium histolyticum, a medication injected directly into the plaque to reduce curvature in selected patients. In the United States, it is approved for adult men with a palpable plaque and curvature of at least 30 degrees.
The protocol involves injections and guided modeling. Bruising, swelling, and pain may occur; in rare cases, a serious injury such as corporal rupture may occur.
Approval in the United States does not mean the medication is automatically available in Brazil. Regulatory status, access, and suitability must be confirmed during the evaluation.
Andractiv Peyronie® is presented by its manufacturer as a vitamin-based dietary supplement. As a supplement, it should not be confused with an intralesional medication or promoted as capable of dissolving the plaque, stabilizing the condition, or correcting curvature.
Any potential use should be discussed in a clinical context and does not replace a urological evaluation, monitoring of the deformity, or treatments indicated for specific goals.
Ointments and creams should not be presented as proven ways to dissolve scar tissue plaques or correct penile curvature. Before using any product, speak with a urologist about the evidence, safety, and treatment goals.
Vitamins, antioxidants, oral medications, injections, or maneuvers used without medical supervision may delay proper evaluation or cause injury. Any recommendation should consider the stage of the condition, anatomy, symptoms, available evidence, and overall health.
Speak with our team about the appointment process; do not start or stop treatment without a medical evaluation.
These approaches may be part of a conservative or multimodal treatment plan. The type of device, duration of use, and treatment goal should be determined and supervised by a qualified professional.
It applies controlled mechanical tension and may be considered to reduce part of the deformity and help preserve or regain length in selected patients. Benefits vary and depend on the protocol, adaptation, and adherence to use.
It may help achieve an erection and be part of rehabilitation strategies in specific situations. Evidence that it permanently corrects curvature or dissolves the plaque when used alone remains limited.
These may contribute through education, functional adaptation, discomfort management, guidance on devices, and support for resuming sexual activity. Massage, laser therapy, therapeutic ultrasound, or exercises should not be presented as proven methods for removing the plaque.
Use depends on a proper indication and guidance. Share your medical history to receive initial direction.
In general, surgery is discussed when the condition is in the chronic phase, with no noticeable progression, and the deformity makes sexual intercourse difficult or causes significant functional impairment. The choice depends on penile length, the complexity of the deformity, and erection quality.
These may be considered when erections are adequate, sufficient length is present, and the deformity is not highly complex. Potential shortening should be discussed before making a decision.
This may be discussed for complex deformities, significant curvature, or structural loss, when erectile function is preserved. It aims to reduce asymmetry but does not guarantee restoration of previous dimensions and may increase the risk of erectile dysfunction.
It may be considered when erectile dysfunction does not respond adequately to other options. The implant addresses erection firmness; residual deformity may require additional reconstructive maneuvers.
Speak with our team about personalized evaluation and planning, with no obligation to proceed with treatment.
Developed by Dr. Paulo Egydio, the technique applies geometric principles to the planning of incisions in the tunica albuginea during reconstructive procedures. It may be considered in the surgical treatment of Peyronie’s Disease and in situations involving penile implant surgery.
The stage of the condition and functional impact come first. The technique is not automatically indicated for anyone who notices curvature, pain, or a plaque; surgery is usually discussed when the condition is stable and sexual intercourse is impaired.
Length, girth, type of deformity, erection firmness, and previous treatments help determine whether reconstructive treatment is indicated and which approach may be considered. The goal is to improve function, without guaranteeing restoration of previous dimensions or the absence of risks.
Erectile dysfunction may occur before, during, or after changes in penile shape. It may be related to vascular, metabolic, neurological, medication-related, or emotional factors, as well as to the deformity itself. For this reason, erection firmness and curvature need to be evaluated separately.
Our team can explain how these symptoms are evaluated together.
The answers below are for educational purposes. Treatment recommendations depend on the evaluation of each case.
There is no single answer. Pain may decrease and the condition may stabilize, but curvature or other deformities may remain. Treatment focuses on specific goals, such as managing symptoms, improving erectile function, or reducing deformity when indicated.
No. Some cases may only require monitoring, while others may receive clinical treatment, intralesional therapy, traction therapy, or rehabilitation. Surgery is mainly reserved for the chronic phase when there is significant functional impairment.
Yes, depending on the stage, symptoms, and treatment goal. Options include observation, pain management, treatment for erectile dysfunction, intralesional therapies, traction therapy, and rehabilitation devices. None of these options is appropriate for every patient.
No. Collagenase is indicated only for selected patient profiles and is subject to specific clinical and regulatory criteria. Plaque location, type of deformity, erectile function, risks, and availability in the country must be evaluated before treatment is considered.
Andractiv Peyronie is a dietary supplement, not an injectable medication or reconstructive procedure. It should not be presented as capable of dissolving the plaque or correcting curvature on its own. Any potential use must be considered by the responsible healthcare professional.
It may help some patients, particularly with goals related to deformity and length, but results vary. Outcomes depend on the device, protocol, duration of use, and adherence, with no guarantee of complete correction.
No. Curvature that has been present since development may be congenital, whereas Peyronie’s Disease usually represents an acquired change. Medical history and a urological examination help distinguish these conditions.
It depends on pain, erection firmness, the degree of deformity, and the couple’s comfort. Painful intercourse or situations in which the penis bends unsafely should not be forced. Guidance can be individualized during the appointment.
Ask our team discreetly; the answers on this page do not replace an individualized evaluation.
The preliminary assessment organizes initial information about symptoms, medical history, and the progression of your condition. It does not replace an appointment, physical examination, diagnosis, or treatment recommendation.
Medical Review: Dr. Paulo Henrique Egydio — CRM-SP 67.482 · RQE 19514.
Institution: Egydio Institute.
Last Updated: September 2026.
This content is intended for educational purposes and does not replace a medical appointment, diagnosis, or prescription. Information about medications and regulatory availability should be confirmed at the time of evaluation.
Send your question by email to Dr. Paulo Egydio’s contact address.